Recent metagenomic studies have probed the fungal microbiome of intensively managed turfgrasses to better understand the organisms present, which may be beneficial or harmful, but the taxonomic resolution is often limited to the family or genus level. This may relate to the common practice of targeting short ribosomal DNA sequences for estimating fungal abundance and phylogenetic relationships. We collected samples of intensively managed creeping bentgrass (Agrostis stolonifera L.) from Guelph, ON, across two growing seasons and obtained 2,204 foliar epiphytic fungal isolates. Sequencing the entire internal transcribed spacer (ITS) region of 251 representative isolates resolved these to 54 species in 31 genera. A comparison of the taxa identified here versus those reported in five metagenomic studies revealed similarities. However, of the 31 genera we identified by sequencing, 13 genera (42%) were not reported in the metagenomic studies related to intensively managed turfgrass systems. The five metagenomic studies identified an average of 44 genera, with 46% (ranging from 4 to 72%) on average being unique to each study. In addition to revealing genera that were not reported in other studies, full-length ITS sequencing had the advantage of being able to resolve to the species level. We could resolve 248 of the sequenced isolates to species with an e-value of 10 −50 , with three left at the genus level. Until sequencing technologies can yield full-length ITS sequencing, laborious traditional culturing followed by sequencing of the entire ITS region can give insights into microbiomes not revealed by current metagenomic methods.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.